Thomas Higgins
Finanzdirektor/CFO bei NEUROMETRIX, INC.
Vermögen: 33 941 $ am 31.05.2024
Profil
Thomas T.
Higgins currently works at NeuroMetrix, Inc., as Chief Financial Officer, Treasurer & Senior VP and Panacos Pharmaceuticals, Inc., as Chief Financial Officer.
Mr. Higgins also formerly worked at Cabot Corp., as Vice President & General Manager-Asia Pacific, V.I.
Technologies, Inc., as Chief Financial Officer & Executive VP-Operations from 1998 to 2005, Caliper Life Sciences, Inc., as Chief Financial Officer & Executive Vice President from 2005 to 2008, and Distrigas of Massachusetts Corp., as President.
Mr. Higgins received his undergraduate degree from Boston University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEUROMETRIX, INC.
0,44% | 02.05.2024 | 8 862 ( 0,44% ) | 33 941 $ | 31.05.2024 |
Aktive Positionen von Thomas Higgins
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUROMETRIX, INC. | Finanzdirektor/CFO | 10.09.2009 |
| PANACOS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Thomas Higgins
| Unternehmen | Position | Ende |
|---|---|---|
Caliper Life Sciences, Inc.
 Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Finanzdirektor/CFO | 01.03.2008 |
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Finanzdirektor/CFO | 15.08.2005 |
| Distrigas of Massachusetts Corp. | Präsident | - |
| CABOT CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Thomas Higgins
| Boston University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CABOT CORPORATION | Process Industries |
| NEUROMETRIX, INC. | Health Technology |
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Electronic Technology |
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Health Technology |
| Distrigas of Massachusetts Corp. |
